Loop diuretics in clinical practice
- Authors
- Oh S.W.; Han S.Y.
- Issue Date
- 2015
- Publisher
- Korean Society of Electrolyte and Blood Pressure Research
- Keywords
- Chronic kidney disease; Furosemide; Loop diuretics
- Citation
- Electrolyte and Blood Pressure, v.13, no.1, pp 17 - 21
- Pages
- 5
- Indexed
- SCOPUS
KCI
- Journal Title
- Electrolyte and Blood Pressure
- Volume
- 13
- Number
- 1
- Start Page
- 17
- End Page
- 21
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/8527
- DOI
- 10.5049/EBP.2015.13.1.17
- ISSN
- 1738-5997
2092-9935
- Abstract
- Diuretics are commonly used to control edema across various clinical fields. Diuretics inhibit sodium reabsorption in specific renal tubules, resulting in increased urinary sodium and water excretion. Loop diuretics are the most potent diuretics. In this article, we review five important aspects of loop diuretics, in particular furosemide, which must be considered when prescribing this medicine: (1) oral versus intravenous treatment, (2) dosage, (3) continuous versus bolus infusion, (4) application in chronic kidney disease patients, and (5) side effects. The bioavailability of furosemide differs between oral and intravenous therapy. Additionally, the threshold and ceiling doses of furosemide differ according to the particular clinical condition of the patient, for example in patients with severe edema or chronic kidney disease. To maximize the efficiency of furosemide, a clear understanding of how the mode of delivery will impact bioavailability and the required dosage is necessary. Copyright © 2015 The Korean Society of Electrolyte Metabolism.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Nephrology and Hypertension > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.